A comprehensive approach to cell and gene therapy research
Cell and gene therapies hold great promise with the potential to change the course of a disease. Read the blog post by Erin Finot, Vice President of Immuno-Oncology & Cell and Gene Therapy, highlighting the challenges and strategies associated with long-term follow-up in gene therapies.
Access our Cell and Gene Therapy Insights Hub below to learn about solutions for the unique challenges biotech sponsors face.
Let’s talk. Complete the form below to schedule a conversation with Erin Finot.
Cell and Gene Therapy Insights Hub
Patient-Focused Strategies for Long-Term Follow-Up in Gene Therapies
Innovative technologies can increase patient engagement and reduce burden
Evolving with the patient: Optimising CAGT post-trial long-term follow-up
Our CAGT experts featured in pharmaphorum
Strengthening Pathways for Cell and Gene Therapies
From the IQVIA Institute for Human Data Science
Cell and Gene Therapy Logistics Management: A holistic approach
How partnerships address challenges in CAGT trial operations
Specialized clinical development for cell-based, novel gene therapies
A dedicated partner in cell and gene therapy clinical research
